Pro Medicus Limited (ASX: PME) has signed a A$53 million, seven-year contract with BayCare, a leading healthcare provider in Florida. Under this deal, PME’s U.S. subsidiary, Visage Imaging, Inc., will deploy its cloud-based Visage 7 Enterprise Imaging Platform, replacing BayCare’s legacy PACS and workflow systems. The implementation, based on a transactional licensing model, will commence immediately, with a go-live target set for late Q3/Q4 of 2025. The agreement further strengthens PME’s presence in the North American integrated delivery network (IDN) market. CEO Dr. Sam Hupert highlighted that 70% of Visage 7’s North American clients now opt for cloud-based solutions, reinforcing PME’s CloudPACS strategy as a standard in healthcare IT.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Feb 04, 2025
Feb 04, 2025
Feb 04, 2025
Feb 03, 2025
Feb 03, 2025
Feb 03, 2025
Feb 03, 2025
Feb 03, 2025
Feb 03, 2025
Jan 31, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.